Prevest Denpro Ltd
Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.
- Market Cap ₹ 648 Cr.
- Current Price ₹ 540
- High / Low ₹ 673 / 332
- Stock P/E 38.4
- Book Value ₹ 79.9
- Dividend Yield 0.19 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 6.76 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | TTM | |
---|---|---|
56 | 59 | |
36 | 39 | |
Operating Profit | 20 | 21 |
OPM % | 36% | 35% |
3 | 3 | |
Interest | 0 | 0 |
Depreciation | 1 | 2 |
Profit before tax | 21 | 22 |
Tax % | 25% | |
16 | 17 | |
EPS in Rs | 13.45 | 14.08 |
Dividend Payout % | 7% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 32% |
1 Year: | 24% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | Sep 2024 | |
---|---|---|
Equity Capital | 12 | 12 |
Reserves | 77 | 84 |
0 | 0 | |
6 | 7 | |
Total Liabilities | 95 | 103 |
27 | 26 | |
CWIP | 0 | 0 |
Investments | 2 | 4 |
66 | 72 | |
Total Assets | 95 | 103 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | |
---|---|
12 | |
-2 | |
-0 | |
Net Cash Flow | 10 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | |
---|---|
Debtor Days | 53 |
Inventory Days | 168 |
Days Payable | 32 |
Cash Conversion Cycle | 189 |
Working Capital Days | 79 |
ROCE % |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
15h - Transcript of conference call with Investors and Analysts held on November 20, 2024
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
1d - Audio recording of earnings call for Q3 results.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
19 Nov - Investor presentation on financial results for HY1 FY25.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
14 Nov - Conference Call w.r.t. Financial Results for the quarter and half year ended on September 30, 2024.
-
Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (LODR) Regulations, 2015 As On Period Ended September 30, 2024)
12 Nov - Disclosure of no deviation in IPO fund utilization.
Annual reports
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptNotesPPT
-
Jun 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Feb 2022TranscriptPPT
-
Dec 2021TranscriptPPT
Product Portfolio
Company manufactures over 100 dental products which comprise of:
a) Clinical Products: Adhesives, Bonding Agents & Etchants, Auxiliaries, Cement and Liners, Composites, Endodontics, Finishing & Polishing, Impression Materials, Oral Care, Orthodontics, Retraction Materials, Temporaries, and Tooth Whitening. [1]
b) Laboratory Products: Acrylics, Auxiliaries, Base Plates & Waxes, and Gypsum Products. [2]
Marquee Product - Resins: Company is the leading manufacturer of high-quality 3D printing resins designed for fabrication of dental crowns, bridges, inlays, onlays, and veneers. It offers several advantages over traditional fabrication methods.[3]
** Hygiene & Disinfectant** : This product is specifically formulated to combat a broad spectrum of pathogens, including bacteria, viruses, and fungi. These products are designed to target high-touch surfaces, medical devices, and equipment.[4]
Product Application
Their dental products find application in endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and for fabrication of prosthesis in dental laboratories. [5]
Prevest Denpro Limited operates with a business model focused on the manufacturing and distribution of dental materials and equipment.[6]